GB2295390A — Analgesic morphine and codeine derivatives
Assigned to BTG International Ltd · Expires 1996-05-29 · 30y expired
What this patent protects
Compounds of Formula I <IMAGE> wherein R1 = H (morphine analogue), CH3 (codeine analogue> R2 = H, alkyl group of 1 to 4 carbon atoms, allyl, cyclopropylmethyl R3 = a group <IMAGE> wherein X1, X2, X3, X4 a…
USPTO Abstract
Compounds of Formula I <IMAGE> wherein R1 = H (morphine analogue), CH3 (codeine analogue> R2 = H, alkyl group of 1 to 4 carbon atoms, allyl, cyclopropylmethyl R3 = a group <IMAGE> wherein X1, X2, X3, X4 and X5 which may be the same or different are separately selected from H, alkyl of 1 to 4 carbon atoms, NH2, NO2 alkoxy group of 1 to 4 carbon atoms, hydroxy, halogen, N-alkyl, group of 1 to 4 carbon atoms, morpholine, or a group COR5 wherein R5 is H, OH, O-alkyl where alkyl is from 1 to 4 carbon atoms, or one of X1 and X2, X2 and X3, X3 and X4 or X4 and X5 together with an alkylene group optionally interrupted by O, S or N of up to 5 atoms in length complete a ring, which are novel provided that not all of X1, X2, X3, X4 and X5 are hydrogen, pharmaceutically acceptable salts thereof are useful for alleviating pain.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.